Pharmaceutics International, Inc.

Overview

Pharmaceutics International, Inc. (Pii) is a contract development and manufacturing organization (CDMO) specializing in drug product development and manufacturing across early-stage, clinical, and commercial volumes. Acquired by Jabil Inc. on February 3, 2025, Pii combines 30+ years of pharmaceutical manufacturing expertise with Jabil's industry-leading automation and manufacturing capabilities.

Core Capabilities

Formulation & Development Services

• Formulation development focused on bioavailability, stability, and adherence
• Contract analytical services for fast, reliable testing and quality compliance
• Solid-state characterization and complex formulation problem-solving

Manufacturing Services

• Aseptic/Injectables: Sterile fill-finish manufacturing for injectable drug products
• Oral Solid Dose: Custom solutions for tablets, soft gels, and liquid oral formulations
• Lyophilization: Freeze-drying capabilities for injectable products
• Prefilled Syringes: Recent $3.6M investment (November 2024) in advanced labeling, fill/finish, and automated visual inspection technologies
• Controlled Substances: DEA-compliant manufacturing and storage for potent and controlled-substance drugs

Secondary Services

• Packaging, labeling, serialization, and kitting
• Quality assurance and regulatory compliance support
• Technology transfer and scale-up from pilot to commercial production

Facilities & Infrastructure

Four dedicated manufacturing and support facilities in Hunt Valley, Maryland:

• Beaver Court (80,000 sq ft): Aseptic manufacturing and oral solid dose production with DEA vaults
• Gilroy Road (72,000 sq ft): Oral research, development, and manufacturing with DEA vaults
• Beaver Dam (52,500 sq ft): Analytical and quality control laboratories
• Golden West (72,500 sq ft): Labeling, serialization, and kitting operations

Quality & Regulatory

• 100% FDA license to operate
• 300+ scientists and support staff
• 5 drug product approvals in 2023
• 90% of clients report effective solutions delivery
• Emphasis on quality assurance, compliance, and transparency